Clinical Trials on AMD - Age-Related Macular Degeneration in Switzerland
Total 2038 results
-
University Hospital Inselspital, BerneActive, not recruitingAge Related Macular DegenerationSwitzerland
-
University Hospital Inselspital, BerneCompletedAge Related Macular DegenerationSwitzerland
-
University Hospital Inselspital, BerneCompletedAge Related Macular DegenerationSwitzerland
-
Berner Augenklinikmedignition AGEnrolling by invitationWet Age-related Macular DegenerationSwitzerland
-
Augenklinik Zurich WestApellis Pharmaceuticals, Inc.RecruitingAge-Related Macular DegenerationSwitzerland
-
BayerRegeneron PharmaceuticalsCompletedWet Age-related Macular DegenerationSwitzerland
-
Vista KlinikNovartisTerminatedNeovascular Age-related Macular DegenerationSwitzerland
-
Dr. med. Katja HatzCenaug FoundationCompletedNeovascular Age-related Macular DegenerationSwitzerland
-
University Hospital Inselspital, BerneNovartisCompletedAge Related Macular DegenerationSwitzerland
-
University Hospital Inselspital, BerneCompletedAge Related MaculopathySwitzerland
-
University Hospital Inselspital, BerneCompletedAge-Related MaculopathiesSwitzerland
-
AllerganMolecular Partners AGTerminatedWet Age-Related Macular DegenerationSwitzerland, France, Czech Republic
-
BayerCompletedWet Age-related Macular DegenerationCanada, Spain, Sweden, Belgium, Argentina, Italy, Korea, Republic of, United Kingdom, China, Denmark, France, Norway, Colombia, Australia, Ireland, Switzerland, Thailand
-
NovartisCompletedWet Age-Related Macular DegenerationUnited Kingdom, Switzerland
-
BayerRecruitingVisual Impairment | Neovascular Age-related Macular Degeneration (nAMD) | Diabetic Macula Edema (DME)Germany, Canada, Denmark, France, Italy, Saudi Arabia, Switzerland, Australia, Finland, Netherlands, Sweden, Norway, United Arab Emirates, Japan, United Kingdom
-
Vista KlinikCompletedAge Related Macular Degeneration | Choroidal NeovascularizationSwitzerland
-
NovartisQLT Inc.Completed
-
NovartisCompletedAge Related Macular Degeneration | Choroidal NeovascularizationSwitzerland
-
NovartisCompletedAge-Related Macular Degeneration (ARMD)Switzerland
-
NovartisCompletedAge Related Macular DegenerationSwitzerland
-
Vista KlinikCompletedAge Related Macular Degeneration | Choroidal NeovascularizationSwitzerland
-
Novartis PharmaceuticalsCompletedAge-related Macular DegenerationGermany, Switzerland
-
University Hospital, Basel, SwitzerlandCompletedAge-Related Macular Degeneration | Choroidal NeovascularizationSwitzerland
-
Hoffmann-La RocheRecruitingNeovascular Age-related Macular Degeneration (nAMD)Belgium, Korea, Republic of, Germany, Spain, United Kingdom, Australia, Italy, Argentina, Israel, Austria, Brazil, France, Singapore, Switzerland, Taiwan, Turkey
-
Hoffmann-La RocheRecruitingNeovascular Age-Related Macular DegenerationBelgium, United States, United Kingdom, Italy, Argentina, Spain, Israel, Australia, Austria, Brazil, Germany, Switzerland, Taiwan, France
-
Novartis PharmaceuticalsCompletedNeovascular Age-related Macular DegenerationGermany, Austria, Belgium, Denmark, Switzerland, France, Netherlands, Portugal, Sweden, Norway
-
Novartis PharmaceuticalsCompletedNeovascular Age-related Macular DegenerationGermany, Turkey, Austria, Canada, Czechia, United Kingdom, Hungary, Italy, Lithuania, Guatemala, France, Ireland, Argentina, Portugal, Spain, Sweden, Greece, Switzerland, Slovakia, Finland, Netherlands, Colombia, Mexico, Panama
-
Institute of Molecular and Clinical Ophthalmology...Boehringer IngelheimActive, not recruitingAge-Related Macular Degeneration | Geographic Atrophy | Visual Field Defect, Central Scotoma of Both EyesSwitzerland
-
University of SouthamptonKing's College London; Medical University of Vienna; University of Michigan; Imperial... and other collaboratorsActive, not recruitingAge-related Macular DegenerationAustria, Switzerland, United Kingdom
-
AllerganCompletedAge-related Macular DegenerationUnited States, Italy, Australia, Israel, Germany, Austria, France, Switzerland
-
BayerRegeneron PharmaceuticalsActive, not recruitingNeovascular Age-Related Macular DegenerationSpain, Korea, Republic of, Czechia, Japan, Singapore, United States, China, Serbia, Lithuania, Taiwan, Australia, Estonia, Austria, Israel, France, Italy, Switzerland, Slovakia, Ukraine, Portugal, Bulgaria, Latvia, Canada, Hungary, Arge... and more
-
Hoffmann-La RocheActive, not recruitingNeovascular Age-related Macular DegenerationUnited States, Korea, Republic of, United Kingdom, Japan, Canada, Turkey, Argentina, Australia, Denmark, France, Germany, Hungary, Italy, Poland, Spain, Singapore, Austria, Brazil, Hong Kong, Israel, Portugal, Russian Federation, Ta... and more
-
Association for Innovation and Biomedical Research...European Vision Institute Clinical Research NetworkActive, not recruitingAtrophy | Age Related Macular Degeneration | Prediction | Intermediate AMDPortugal, France, Germany, Ireland, Italy, Netherlands, Spain, Switzerland, United Kingdom
-
Ophthotech CorporationTerminatedAge-Related Macular DegenerationItaly, Canada, Switzerland, United States, United Kingdom, Austria, Belgium, Brazil, Czechia, Estonia, Latvia, Poland, Slovakia
-
Novartis PharmaceuticalsCompletedNeovascular Age-related Macular DegenerationUnited States, Czechia, Italy, Taiwan, Australia, Israel, Belgium, France, Spain, Germany, Korea, Republic of, Portugal, Sweden, Netherlands, Malaysia, Switzerland
-
Chengdu Kanghong Biotech Co., Ltd.TerminatedNeovascular Age-related Macular DegenerationUnited States, Argentina, Australia, Austria, Belgium, Canada, Chile, Colombia, Germany, Hong Kong, Lithuania, Mexico, Netherlands, New Zealand, Peru, Philippines, Poland, Portugal, Singapore, Spain, Switzerland, Taiwan
-
Boehringer IngelheimTerminatedAge-related Macular DegenerationUnited States, Switzerland
-
Hoffmann-La RocheRecruitingDiabetic Macular Edema | Neovascular Age-related Macular DegenerationGermany, Croatia, Japan, United Kingdom, Spain, United States, Italy, Switzerland, Canada, France, Australia, Singapore, Israel, Puerto Rico, United Arab Emirates, Bulgaria, Chile, Czechia
-
Novartis PharmaceuticalsCompletedNeovascular (Wet) Age-related Macular DegenerationGermany, Switzerland, Netherlands
-
University Hospital Inselspital, BerneTerminatedAge-related Macular Degeneration | Macular Edema | Retinal Vein Occlusion | Central Serous Chorioretinopathy | Retinal NeovascularizationSwitzerland
-
BayerTerminatedMacular DegenerationHong Kong, Korea, Republic of, United States, Canada, Switzerland, Spain, Japan, Italy, Czech Republic, Australia, Austria, Slovakia, Germany, Hungary, Israel, Chile, France, Colombia
-
Novartis PharmaceuticalsCompletedAge-related Macular DegenerationUnited States, Austria, Czechia, Italy, Taiwan, Belgium, Germany, Australia, Israel, Canada, France, Spain, Korea, Republic of, United Kingdom, Portugal, Netherlands, Sweden, Argentina, Malaysia, Switzerland
-
Hoffmann-La RocheTerminatedGeographic AtrophyCanada, United States, Belgium, Peru, Argentina, Australia, Austria, Denmark, France, Germany, Hungary, Italy, Mexico, Netherlands, Poland, Slovakia, Spain, Switzerland, United Kingdom
-
Hoffmann-La RocheTerminatedGeographic AtrophyUnited States, United Kingdom, Netherlands, Germany, Belgium, Poland, Spain, Argentina, Australia, Hungary, Italy, Portugal, France, Turkey, Austria, Russian Federation, Mexico, Peru, Denmark, Slovakia, Sweden, Switzerland
-
Hoffmann-La RocheTerminatedGeographic AtrophyUnited States, United Kingdom, Germany, France, Turkey, Australia, Austria, Belgium, Canada, Denmark, Hungary, Italy, Poland, Slovakia, Spain, Switzerland, Portugal, Netherlands, Peru
-
Novartis PharmaceuticalsCompletedAge-related Macular Degeneration | Choroidal NeovascularizationKorea, Republic of, Croatia, Germany, India, Russian Federation, Turkey, United Kingdom, Egypt, Israel, Belgium, Denmark, Hungary, Slovenia, Spain, Switzerland, Italy, Portugal, Slovakia, Chile
-
NovartisCompletedDiabetic Macular EdemaSwitzerland
-
University Hospital Inselspital, BerneTerminatedDiabetic Macular EdemaSwitzerland
-
University Hospital Inselspital, BerneUniversity of BernCompletedDiabetic Macular EdemaSwitzerland
-
Sebastian WolfUniversity of BernCompletedMacular Edema | CNVSwitzerland